BGF Retail to bolster its presence in Mongolia CU is No.1 convenience store brand there with 74% market share
Translated by Kim So-in 공개 2022-06-14 08:04:24
이 기사는 2022년 06월 14일 08시01분 thebell에 표출된 기사입니다
BGF Retail is stepping up efforts to strengthen its presence in Mongolia.BGF Retail, which operates CU convenience store chain, entered the Mongolian and Malaysian markets in 2018 and 201 through master franchise contracts with local firms. Under the contract, the master franchisor hands over control of franchising activities in a specified region to a person or entity.
When CU entered Mongolia, the country lacked convenience stores with a systematic sales system and infrastructure for related businesses.
Mongolia, however, was seen as a promising market for Korean convenience store operators given the number of people aged under 40 taking up nearly 70% of the total population. Most of the population was also concentrated in Ulaanbaatar, the capital city of Mongolia.
It actually took the company about 26 months to open its 100th outlet in the country, while it only took 18 months to open its 200th outlet.
CU is currently the No.1 convenience store brand in Mongolia with a market share of over 74%. Around 1,000 people visit CU stores in Mongolia on average every day, which is about three times more than the number of visitors at its stores in Korea.
CU made forays into the Mongolian market through a franchise deal with local retailer Central Express. BGF Retail purchased a 9.9% stake in Central Express in November 2019 and acquired additional 50.83 million shares in June 2021.
CU’s growth has helped Central Express to increase its revenue and list its shares on the Mongolian Stock Exchange in November 2021. Central Express raised 40.1 billion Tugrik in the country’s largest ever IPO.
BGF Retail plans to introduce its BGF global IT system in September to help its Mongolian business to maintain stable growth in the future. (Reporting by Kyu-seok Park)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- [i-point]'자가면역질환 신약' 이노보테라퓨틱스, 미국 임상 1상 '성공적'
- [i-point]폴라리스오피스, 엔비디아 ‘커넥트’ 공식 파트너 선정
- [i-point]신성이엔지, 한국종합기술·다스코와 연료전지 발전사업 협약
- [i-point]신테카바이오, 'PEGS 보스턴 2025' 참가
- [AACR 2025]첫 구두발표 진씨커, 경쟁사 넘보는 '유전자가위 액체생검'
- [AACR 2025]이뮨온시아 'CD47' 안전성 굳히기 "경쟁약과 다르다"
- [AACR 2025]항암 신약 항체 대신 '페라틴', 셀레메디 플랫폼 데뷔전
- [AACR 2025]근거 쌓는 '루닛 스코프' 빅파마 공동연구 쇼케이스
- [변곡점 선 콜마비앤에이치]변화의 마지막 카드, 경영진 교체 '강수' 두나
- [변곡점 선 콜마비앤에이치]속절없는 주가 하락 '트리거', 주가 부양 의지 없었나